POLR2D Human

Polymerase II Polypeptide D Human Recombinant
Shipped with Ice Packs
In Stock

Description

Expression Profile

  • Ubiquitous expression in human tissues, with elevated levels in the brain, spinal cord, and embryonic structures .

  • Localizes to the nucleus and P-bodies, indicating roles in transcription and mRNA processing .

Core Transcriptional Machinery

POLR2D is indispensable for Pol II-mediated transcription:

  • Binds translation initiation factors to regulate mRNA export under stress .

  • Facilitates transcription initiation by stabilizing Pol II interactions with DNA .

Developmental Necessity

  • Zebrafish Studies: Homozygous polr2d mutants exhibit:

    • Delayed somitogenesis and hypoplasia (e.g., small eyes, cardiac edema) .

    • Increased apoptosis (198.4 ± 25.2 dead cells in mutant heads vs. 54.3 ± 10.7 in wild-type) .

    • Lethality by 60 hours post-fertilization due to disrupted housekeeping gene expression (e.g., actb1, rpl13a) .

  • Rescue Experiments: Injecting wild-type polr2d mRNA restores normal development .

Cancer Implications

POLR2D is dysregulated in multiple cancers:

Cancer TypeExpression ChangeClinical ImpactSources
Colorectal cancerUpregulatedCorrelates with tumor progression and metastasis
Ovarian cancerUpregulatedLinked to chemotherapy resistance
Prostate cancerUpregulatedAssociated with androgen receptor signaling

Stress Response Mechanisms

  • Yeast homolog RPB4 aids survival under suboptimal conditions (e.g., heat shock, oxidative stress) .

  • Human POLR2D knockdown via shRNA impairs cell proliferation, confirming its protective role .

Zebrafish as a Vertebrate Model

  • CRISPR/Cas9-generated polr2d mutants replicate human Pol II dysfunction, providing insights into developmental defects .

  • Key Phenotypes:

    • Somitogenesis delay (onset at 11 hpf).

    • 48 hpf hypoplasia rescued by mRNA supplementation .

Pharmacological Interactions

  • Chemical Modulators:

    • Aflatoxin B1 and benzo[a]pyrene upregulate POLR2D expression .

    • Valproic acid and arsenite downregulate its mRNA levels .

Evolutionary Conservation and Research Gaps

  • POLR2D is conserved from yeast (S. cerevisiae) to humans, with 85% amino acid similarity in vertebrates .

  • Unresolved Questions:

    • Mechanistic role in stress adaptation beyond transcription.

    • Tissue-specific regulatory networks in cancer.

Product Specs

Introduction
Polymerase II Polypeptide D (POLR2D) belongs to the eukaryotic RPB4 RNA polymerase subunit family. It represents the fourth largest subunit within RNA polymerase II. Pol II plays a crucial role as the primary component of the basal RNA polymerase II transcription machinery, responsible for synthesizing messenger RNA in eukaryotic cells. Studies in yeast indicate that the POLR2D subunit associates with the polymerase, particularly under suboptimal growth conditions, suggesting a potential role in stress protection. Functionally, POLR2D catalyzes the transcription of DNA into RNA utilizing the 4 ribonucleoside triphosphates as substrates.
Description
Recombinantly produced in E. coli, POLR2D Human is a single, non-glycosylated polypeptide chain. It comprises 165 amino acids (1-142) and exhibits a molecular mass of 18.7 kDa. The protein is engineered with a 23 amino acid His-tag at the N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
The product appears as a sterile-filtered solution, colorless in appearance.
Formulation
The POLR2D solution is provided at a concentration of 1 mg/ml. It is formulated in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.4 M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the product frozen at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. To maintain product integrity, avoid repeated freeze-thaw cycles.
Purity
Analysis by SDS-PAGE indicates a purity greater than 90%.
Synonyms
HSRBP4, HSRPB4, RBP4, RPB16, DNA-directed RNA polymerase II subunit RPB4, RNA polymerase II subunit B4, DNA-directed RNA polymerase II subunit D, RNA polymerase II 16 kDa subunit, POLR2D.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMAAGGSD PRAGDVEEDA SQLIFPKEFE TAETLLNSEV HMLLEHRKQQ NESAEDEQEL SEVFMKTLNY TARFSRFKNR ETIASVRSLL LQKKLHKFEL ACLANLCPET AEESKALIPS LEGRFEDEEL QQILDDIQTK RSFQY.

Q&A

What is POLR2D and what is its fundamental role in human cells?

POLR2D is a subunit of RNA polymerase II (RNA Pol II), one of the key enzymes responsible for transcribing DNA into RNA in eukaryotic cells. RNA Pol II specifically transcribes DNA to synthesize precursors of mRNA and most snRNA and microRNA . As part of the RNA Pol II complex, POLR2D participates in the transcription cycle, which includes promoter access, pre-initiation complex assembly, transcription initiation, promoter clearance, and elongation .

Interestingly, unlike some other RNA Pol II subunits, POLR2D appears to be involved in the transcription of only a subset of genes, suggesting it has a specialized regulatory role rather than being essential for all RNA Pol II-mediated transcription . This specificity makes POLR2D particularly important for researchers studying mechanisms of targeted gene regulation.

Where is POLR2D protein localized within human cells?

POLR2D exhibits an intriguing localization pattern within human cells. While it is found in both the nucleus and cytoplasm, research has demonstrated that its localization is significantly higher in the cytoplasm . This is somewhat unexpected for an RNA polymerase subunit, as transcription primarily occurs in the nucleus.

The substantial cytoplasmic localization suggests that POLR2D may have additional functions beyond its role in the nuclear RNA Pol II complex . This dual localization pattern provides an important avenue for research into potential non-canonical functions of POLR2D outside of direct transcriptional regulation.

What are the standard experimental methods used to study POLR2D expression?

Researchers employ several complementary approaches to investigate POLR2D expression and function:

MethodApplicationAdvantages
qRT-PCRQuantification of mRNA expressionHigh sensitivity, quantitative results
Western BlottingProtein level detectionProtein size confirmation, semi-quantitative
ImmunofluorescenceSubcellular localizationSpatial distribution within cells
RNA-seqTranscriptome-wide expressionComprehensive gene expression profiling
shRNA/siRNA KnockdownFunctional studiesAssess effects of reduced expression
Chromatin ImmunoprecipitationDNA binding sitesIdentify genomic regions of interaction

When designing experiments to study POLR2D, it's important to consider both its nuclear and cytoplasmic localization. For instance, subcellular fractionation prior to Western blotting can provide insights into compartment-specific expression levels . Additionally, when performing knockdown studies, researchers should verify suppression in both compartments to ensure comprehensive functional analysis.

How is POLR2D expression altered in cancer and what is its prognostic significance?

POLR2D has been identified as a commonly overexpressed gene with prognostic significance across multiple cancer types. Comprehensive analysis of cancer datasets reveals:

This consistent association across multiple cancer types suggests that POLR2D may play a fundamental role in cancer progression and could serve as a valuable prognostic biomarker . Receiver Operating Characteristic (ROC) analysis has shown that POLR2D RNA levels can serve as particularly strong diagnostic markers for LUSC and COAD tumors .

When designing studies to evaluate POLR2D as a biomarker, researchers should consider using both tissue microarrays for protein expression and RNA-seq data for transcriptional analysis to establish robust correlations with clinical outcomes.

What are the effects of POLR2D knockdown on cellular phenotypes?

Experimental studies using shRNA-mediated knockdown of POLR2D have demonstrated significant effects on cancer cell phenotypes:

POLR2D knockdown experiments in A549 (lung cancer) and MDA MB 231 (breast cancer) cell lines revealed:

  • Significant inhibition of cell proliferation in both short-term assays and long-term colony formation assays

  • Suppressed long-term growth capabilities and reduced ability to form colonies

  • Decreased expression of only a subset of genes, indicating selective transcriptional effects rather than global transcriptional inhibition

These findings indicate that POLR2D is required for cancer cell proliferation, making it a potential therapeutic target. When designing knockdown experiments, researchers should use multiple shRNAs targeting different regions of POLR2D to confirm specificity and minimize off-target effects. Additionally, rescue experiments with shRNA-resistant POLR2D constructs can confirm phenotype specificity.

How does POLR2D contribute to RNA polymerase II function in transcriptional regulation?

The transcription cycle consists of at least eight distinct major steps at which transcription could be rate-limiting . POLR2D's role in this process appears to be specialized:

  • Selective Gene Regulation: Unlike typical RNA Pol II subunits that affect all transcription, POLR2D knockdown studies show that it regulates only a subset of genes

  • Step-Specific Functions: Within the transcription cycle, POLR2D may be involved in specific steps such as:

    • Pre-initiation complex (PIC) assembly

    • Promoter clearance

    • Promoter-proximal pausing

    • Productive elongation

  • Specialized Complex Formation: POLR2D likely participates in specialized RNA Pol II complexes that target specific promoters or respond to particular regulatory signals

  • Transcription Factor Interactions: POLR2D may mediate interactions with specific transcription factors or co-regulators at target promoters

When investigating POLR2D's transcriptional functions, researchers should employ techniques like ChIP-seq to identify genome-wide binding sites, PRO-seq to measure nascent transcription, and protein interaction studies to identify POLR2D-specific binding partners within the transcriptional machinery.

What experimental approaches can distinguish between POLR2D's nuclear and cytoplasmic functions?

To elucidate the distinct roles of nuclear versus cytoplasmic POLR2D, researchers can employ several specialized approaches:

ApproachMethodologyInsights Gained
Subcellular FractionationBiochemical separation of nuclear and cytoplasmic compartmentsQuantitative distribution of POLR2D
Domain Mutation AnalysisCreating mutants with altered localization signalsDomains responsible for compartment-specific functions
Compartment-Restricted ExpressionExpression of POLR2D with nuclear export or import signalsFunctions associated with specific compartments
Proximity LabelingBioID or APEX2 fusion proteins in specific compartmentsCompartment-specific interaction partners
Chromatin Run-On AssaysMeasuring nascent transcription after compartment-specific depletionDirect effects on transcription

These approaches would help researchers determine whether cytoplasmic POLR2D represents a regulatory pool for nuclear function or has entirely separate cytoplasmic roles. When designing such experiments, careful validation of compartment-specific manipulations is essential, as is controlling for potential compensatory mechanisms between compartments.

How does POLR2D expression correlate with other RNA polymerase subunits in different cancers?

The relationship between POLR2D and other RNA polymerase subunits reveals interesting patterns across cancer types:

  • Differential Regulation Patterns: While POLR2D shows consistent overexpression across multiple cancers, other subunits show more variable patterns:

    • POLR2K and POLR2H: Commonly amplified and overexpressed

    • POLR3D: Typically deleted and downregulated

    • POLR2F: Hypermethylated and silenced in breast cancer but hypomethylated and overexpressed in lung cancer

  • Genetic vs. Epigenetic Regulation: Different subunits are regulated by distinct mechanisms:

    • POLR2H: Amplified in >40% of lung adenocarcinoma samples

    • POLR2F: Regulated by promoter methylation

    • POLR2L: Silenced due to methylation in non-small cell lung cancer

  • Functional Specialization: Different subunits appear to have specialized roles in cancer:

    • POLR2D: Affects a subset of genes important for cell proliferation

    • CD3EAP (RNA Pol I subunit): Regulates autophagy and cell cycle progression

This complex pattern suggests that RNA polymerase subunits play distinct roles in cancer development, with some having more universal effects and others showing context-dependent functions. Researchers investigating these relationships should consider integrated approaches combining genetic, epigenetic, and functional analyses.

What are the key considerations for designing POLR2D knockdown or knockout studies?

When designing experimental interventions targeting POLR2D, researchers should consider:

  • Selection of appropriate model systems: Cell lines with high endogenous POLR2D expression (such as A549 and MDA-MB-231) have shown reproducible phenotypes following knockdown

  • Validation of knockdown efficiency: Using both qRT-PCR and Western blot to confirm reduction at both RNA and protein levels

  • Use of multiple independent knockdown/knockout strategies: Multiple shRNAs, siRNAs, or CRISPR guides targeting different regions of POLR2D to confirm specificity

  • Rescue experiments: Expression of shRNA-resistant POLR2D constructs to confirm phenotype specificity

  • Timing considerations: Since POLR2D affects cell proliferation, phenotypes should be assessed before significant selective pressure occurs

A good experimental design requires a strong understanding of the system you are studying and should follow the five key steps: consider your variables and their relationships, write a specific testable hypothesis, design treatments to manipulate your independent variable, assign subjects to groups, and plan how to measure your dependent variable .

How can researchers effectively study POLR2D's selective transcriptional effects?

To investigate POLR2D's role in regulating specific gene subsets:

  • Global transcriptomic analysis: RNA-seq before and after POLR2D manipulation to identify affected genes

  • Categorization of target genes: Functional classification of POLR2D-dependent genes to identify common pathways or regulatory features

  • Chromatin binding studies: ChIP-seq to determine where POLR2D binds in the genome

  • Nascent RNA analysis: PRO-seq or GRO-seq to distinguish direct transcriptional effects from secondary effects

  • Integrated analysis with other factors: Comparison with binding patterns of other transcription factors or chromatin marks

When analyzing transcriptomic data after POLR2D manipulation, researchers should focus on identifying gene categories or pathways most affected, as POLR2D has been shown to regulate only a subset of genes rather than causing global transcriptional changes .

What approaches can effectively assess POLR2D's role in cancer progression?

For researchers investigating POLR2D's contribution to cancer:

  • Patient-derived samples: Analysis of POLR2D expression in matched tumor and normal tissues across cancer types

  • Correlation with clinical outcomes: Kaplan-Meier survival analysis based on POLR2D expression levels

  • In vivo models: Xenograft studies with POLR2D knockdown or overexpression

  • Mechanistic studies: Investigation of how POLR2D affects known cancer hallmarks (proliferation, migration, metabolism)

  • Therapeutic targeting: Assessment of potential vulnerabilities created by POLR2D overexpression

The consistent finding that POLR2D is overexpressed and associated with poor prognosis across multiple cancer types suggests it may be a valuable therapeutic target . Researchers should consider combinatorial approaches that target both POLR2D and interacting pathways to develop effective intervention strategies.

How does POLR2D function integrate with general transcriptional regulation models?

POLR2D's role should be considered within the broader context of transcriptional regulation:

  • Transcription cycle steps: The transcription cycle involves at least eight distinct major steps at which transcription could be rate-limiting and activators could potentially act to increase transcription rate

  • Promoter accessibility: Transcription begins with Pol II gaining access to the promoter, which may require clearing of nucleosomes

  • Pre-initiation complex: Assembly of the pre-initiation complex on the core promoter involves multiple factors

  • Promoter-proximal pausing: Regulation at the pause region represents a key control point

  • Specialized regulation by POLR2D: POLR2D appears to function in transcribing only a subset of genes, suggesting a specialized regulatory role

Understanding how POLR2D fits into these established models of transcriptional regulation will help researchers develop more targeted hypotheses about its specific functions and regulatory mechanisms.

What are the potential interactions between POLR2D and chromatin modifications?

While the search results don't directly address POLR2D's relationship with chromatin modifications, several research directions are warranted:

  • Co-occurrence analysis: Investigating whether POLR2D binding correlates with specific histone modifications

  • Chromatin accessibility: Determining if POLR2D preferentially associates with open chromatin regions

  • Chromatin modifying enzymes: Exploring potential interactions between POLR2D and histone modifiers

  • Pioneer factor activity: Investigating whether POLR2D participates in opening closed chromatin regions

The search results mention that some transcription factors can reorganize nucleosomes or covalently modify chromatin, changing the gene's chromatin architecture . Researchers studying POLR2D should consider whether it participates in or is affected by such mechanisms.

How can computational approaches enhance POLR2D functional studies?

Advanced computational methods can significantly enhance POLR2D research:

  • Integrated multi-omics analysis: Combining ChIP-seq, RNA-seq, and proteomics data to build comprehensive models of POLR2D function

  • Network analysis: Identifying gene regulatory networks involving POLR2D and its target genes

  • Motif discovery: Determining if POLR2D-regulated genes share common regulatory elements

  • Structural modeling: Predicting interaction interfaces between POLR2D and other factors

  • Machine learning approaches: Using AI to identify patterns in POLR2D binding or expression data that predict functional outcomes

When designing computational studies, researchers should leverage publicly available datasets from resources like TCGA and GTEx to validate findings across multiple tumor types and normal tissues, as POLR2D shows consistent overexpression across diverse cancers .

Product Science Overview

Structure and Characteristics

The recombinant human POLR2D is typically produced in E. coli and is a single, non-glycosylated polypeptide chain. It contains 165 amino acids, with a molecular mass of approximately 18.7 kDa . The recombinant version often includes a His-tag at the N-terminus to facilitate purification through chromatographic techniques .

Function in Transcription

POLR2D is part of the RNA polymerase II complex, which is essential for the synthesis of messenger RNA (mRNA) in eukaryotic cells. This complex is composed of multiple subunits, and POLR2D plays a role in the assembly and stability of the polymerase complex. The RNA polymerase II complex is responsible for transcribing DNA into pre-mRNA, which undergoes further processing to become mature mRNA. This mRNA is then translated into proteins, which are essential for various cellular functions.

Applications in Research

Recombinant POLR2D is widely used in biochemical and molecular biology research. It is utilized to study the mechanisms of transcription and the role of RNA polymerase II in gene expression. Researchers use recombinant POLR2D to investigate the interactions between different subunits of the RNA polymerase II complex and to understand how mutations in these subunits can affect transcription and lead to various diseases.

Clinical Significance

Mutations or dysregulation of RNA polymerase II subunits, including POLR2D, can lead to various genetic disorders and diseases. Understanding the function and structure of POLR2D can provide insights into the molecular basis of these conditions and potentially lead to the development of targeted therapies.

In summary, Polymerase II Polypeptide D (Human Recombinant) is a vital tool in the study of transcription and gene expression. Its recombinant form allows researchers to explore the intricate details of RNA polymerase II function and its role in cellular processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.